Diagnostic performance of CT, PET, side-by-side, and fused image interpretations for restaging of non-Hodgkin lymphoma

Annals of Nuclear Medicine

Volumn 21, Issue 4, 2007, Pages 189-196

  Nogami, Munenobu ^a   Nakamoto, Yuji ^b   Sakamoto, Setsu ^a   Fukushima, Kazuto ^c   Okada, Tomohisa ^d   Saga, Tsuneo ^b   Higashi, Tatsuya ^b   Senda, Michio ^e   Matsui, Toshimitsu ^f   Sugimura, Kazuro ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^d KOBE CITY MEDICAL CENTER GENERAL HOSPITAL   (Japan)

^e INSTITUTE OF BIOMEDICAL RESEARCH AND INNOVATION   (Japan)

^f KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

CT; Image fusion; Lymphoma; PET

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; MALE; NONHODGKIN LYMPHOMA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; BRAIN; CANCER STAGING; IMAGE PROCESSING; LABORATORY DIAGNOSIS; METHODOLOGY; MIDDLE AGED; PATHOLOGY; RADIOGRAPHY; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; STATISTICAL MODEL;

ADULT; AGED; BRAIN; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; MODELS, STATISTICAL; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 34547671046     PISSN: 09147187     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12149-007-0015-1     Document Type: Article

References (26)

1. C Messa V Bettinardi M Picchio E Pelosi C Landoni L Gianolli 2004 PET/CT in diagnostic oncology Q J Nucl Med Mol Imaging 48 2 66 75
2. T Klose R Leidl I Buchmann HJ Brambs SN Reske 2000 Primary staging of lymphomas: cost-effectiveness of FDG-PET versus computed tomography Eur J Nucl Med 27 10 1457 64
3. NG Schaefer TF Hany C Taverna B Seifert KD Stumpe GK von Schulthess 2004 Non-Hodgkin lymphoma and Hodgkin disease: coregistered FDG PET and CT at staging and restaging: do we need contrast-enhanced CT? Radiology 232 3 823 9
4. L Kostakoglu SJ Goldsmith 2000 Fluorine-18 fluorodeoxyglucose positron emission tomography in the staging and follow-up of lymphoma: is it time to shift gears? Eur J Nucl Med 27 10 1564 78
5. TF Hany HC Steinert GW Goerres A Buck GK von Schulthess 2002 PET diagnostic accuracy: improvement with in-line PET-CT system: initial results Radiology 225 2 575 81
6. C Schiepers JE Filmont J Czernin 2003 PET for staging of Hodgkin's disease and non-Hodgkin's lymphoma Eur J Nucl Med Mol Imaging 30 Suppl 1 S82 8
7. KD Stumpe M Urbinelli HC Steinert C Glanzmann A Buck GK von Schulthess 1998 Whole-body positron emission tomography using fluorodeoxyglucose for staging of lymphoma: effectiveness and comparison with computed tomography Eur J Nucl Med 25 7 721 8
8. PJ Hoskin 2002 FDG PET in the management of lymphoma: a clinical perspective Eur J Nucl Med Mol Imaging 29 4 449 51
9. K Spaepen S Stroobants G Verhoef L Mortelmans 2003 Positron emission tomography with [(18)F]FDG for therapy response monitoring in lymphoma patients Eur J Nucl Med Mol Imaging 30 Suppl 1 S97 105
10. GM Segall 2001 FDG PET imaging in patients with lymphoma: a clinical perspective J Nucl Med 42 4 609 10
11. H Schoder J Meta C Yap M Ariannejad J Rao ME Phelps 2001 Effect of whole-body (18)F-FDG PET imaging on clinical staging and management of patients with malignant lymphoma J Nucl Med 42 8 1139 43
12. G Jerusalem Y Beguin MF Fassotte 1999 Whole-body positron emission tomography using 18F-fluorodeoxyglucose for posttreatment evaluation in Hodgkin's disease and non-Hodgkin's lymphoma has higher diagnostic and prognostic value than classical computed tomography scan imaging Blood 94 2 429 33
13. K Spaepen S Stroobants P Dupont P Vandenberghe J Maertens G Bormans 2003 Prognostic value of pretransplantation positron emission tomography using fluorine 18-fluorodeoxyglucose in patients with aggressive lymphoma treated with high-dose chemotherapy and stem cell transplantation Blood 102 1 53 9
14. T Beyer DW Townsend T Brun PE Kinahan M Charron R Roddy 2000 A combined PET/CT scanner for clinical oncology J Nucl Med 41 8 1369 79
15. P Reinartz FJ Wieres W Schneider A Schur U Buell 2004 Side-by-side reading of PET and CT scans in oncology: which patients might profit from integrated PET/CT? Eur J Nucl Med Mol Imaging 31 11 1456 61
16. LS Freudenberg G Antoch P Schutt 2004 FDG-PET/CT in re-staging of patients with lymphoma Eur J Nucl Med Mol Imaging 31 3 325 9
17. H Schoder SM Larson HW Yeung 2004 PET/CT in oncology: integration into clinical management of lymphoma, melanoma, and gastrointestinal malignancies J Nucl Med 45 Suppl 1 72S 81S
18. GK von Schulthess HC Steinert TF Hany 2006 Integrated PET/CT: Current applications and future directions Radiology 238 2 405 22
19. Y Nakamoto S Sakamoto T Okada 2005 Accuracy of image fusion using a fixation device for whole-body cancer imaging AJR Am J Roentgenol 184 6 1960 6
20. CG Diederichs L Staib G Glatting HG Beger SN Reske 1998 FDG PET: elevated plasma glucose reduces both uptake and detection rate of pancreatic malignancies J Nucl Med 39 6 1030 3
21. M Tatsumi H Kitayama H Sugahara N Tokita H Nakamura Y Kanakura 2001 Whole-body hybrid PET with 18F-FDG in the staging of non-Hodgkin's lymphoma J Nucl Med 42 4 601 8
22. M Tatsumi C Cohade Y Nakamoto EK Fishman RL Wahl 2005 Direct comparison of FDG PET and CT findings in patients with lymphoma: initial experience Radiology 237 3 1038 45
23. PP Carbone HS Kaplan K Musshoff DW Smithers M Tubiana 1971 Report of the committee on Hodgkin's disease staging classification Cancer Res 31 11 1860 1
24. D Delbeke 1999 Oncological applications of FDG PET imaging: brain tumors, colorectal cancer, lymphoma and melanoma J Nucl Med 40 4 591 603
25. M Hoffmann K Kletter M Diemling A Becherer F Pfeffel V Petkov 1999 Positron emission tomography with fluorine-18-2-fluoro-2-deoxy-d-glucose (F18-FDG) does not visualize extranodal B-cell lymphoma of the mucosa-associated lymphoid tissue (MALT)-type Ann Oncol 10 10 1185 9
26. M Karam L Novak J Cyriac A Ali T Nazeer F Nugent 2006 Role of fluorine-18 fluoro-deoxyglucose positron emission tomography scan in the evaluation and follow-up of patients with low-grade lymphomas Cancer 175 183